AAAAAA
Results:
1-7
|
Results: 7
Authors:
Wolber, J
McIntyre, DJO
Rodrigues, LM
Carnochan, P
Griffiths, JR
Leach, MO
Bifone, A
Citation: J. Wolber et al., In vivo hyperpolarized Xe-129 NMR spectroscopy in tumors, MAGN RES M, 46(3), 2001, pp. 586-591
Authors:
Flower, MA
Zweit, J
Hall, AD
Burke, D
Davies, MM
Dworkin, MJ
Young, HE
Mundy, J
Ott, RJ
McCready, VR
Carnochan, P
Allen-Mersh, TG
Citation: Ma. Flower et al., Cu-62-PTSM and PET used for the assessment of angiotensin II-induced bloodflow changes in patients with colorectal liver metastases, EUR J NUCL, 28(1), 2001, pp. 99-103
Authors:
Burke, D
Carnochan, P
Glover, C
Allen-Mersh, TG
Citation: D. Burke et al., Correlation between tumour blood flow and fluorouracil distribution in a hypovascular liver metastasis model, CLIN EXP M, 18(7), 2001, pp. 617-622
Authors:
Bruyndonckx, P
Wang, YG
Tavernier, S
Carnochan, P
Citation: P. Bruyndonckx et al., Design and performance of a data acquisition system for VUB-PET, IEEE NUCL S, 48(1), 2001, pp. 150-156
Authors:
Lewis, JS
Dearling, JLJ
Sosabowski, JK
Zweit, J
Carnochan, P
Kelland, LR
Coley, HM
Blower, PJ
Citation: Js. Lewis et al., Copper bis(diphosphine) complexes: radiopharmaceuticals for the detection of multi-drug resistance in tumours by PET, EUR J NUCL, 27(6), 2000, pp. 638-646
Authors:
Carnochan, P
Brooks, R
Citation: P. Carnochan et R. Brooks, Radiolabelled 5 '-iodo-2 '-deoxyuridine: A promising alternative to [F-18]-2-fluoro-2-deoxy-D-glucose for PET studies of early response to anticancertreatment, NUCL MED BI, 26(6), 1999, pp. 667-672
Authors:
Brooks, RC
Carnochan, P
Vollano, JF
Powell, NA
Zweit, J
Sosabowski, JK
Martellucci, S
Darkes, MC
Fricker, SP
Murrer, BA
Citation: Rc. Brooks et al., Metal complexes of bleomycin: Evaluation of [Rh-105]-bleomycin for use in targeted radiotherapy, NUCL MED BI, 26(4), 1999, pp. 421-430
Risultati:
1-7
|